MediPharm Labs (TSE:LABS) Hits New 12-Month Low – What’s Next?

MediPharm Labs Corp. (TSE:LABSGet Free Report)’s stock price hit a new 52-week low during trading on Thursday . The stock traded as low as C$0.07 and last traded at C$0.06, with a volume of 1144784 shares changing hands. The stock had previously closed at C$0.07.

MediPharm Labs Price Performance

The company has a market cap of C$26.72 million, a price-to-earnings ratio of -1.63 and a beta of 0.88. The company has a debt-to-equity ratio of 5.90, a quick ratio of 3.10 and a current ratio of 3.11. The company’s 50 day moving average price is C$0.07 and its 200 day moving average price is C$0.07.

MediPharm Labs Company Profile

(Get Free Report)

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.

Featured Stories

Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.